Skip to content

Microbot Medical MBOT Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-27.6%+4.8pp-32.4%-0.6pp-31.9%+37.9pp-69.8%-3.3pp-66.5%+218pp
Return on invested capital-33%+6.3pp-39.3%-2.2pp-37.1%+52.6pp-89.6%-10.8pp-78.9%+754pp
Liquidity
Current ratio22.6×-0.7×23.3×-4.2×27.5×+15.5×12.1×-4.1×16.2×+13.8×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$1.10-34.9%$1.69+4.1%$1.63+95.5%$0.83-10.7%$0.93+313%
Valuation
Market capitalization$128.28M+36.1%$134.32M-16.6%$161.02M+72.9%$93.13M+77.5%$52.46M+177%
Price / book1.7×-1.4×1.7×-0.3×2.1×-1.0×3.1×+1.3×1.8×-3.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Microbot Medical's ratios come from?
Every ratio is computed from Microbot Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.